Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07571343 · ClinicalTrials.gov registry record · NA

Fueling Labor: Protein Supplementation for Intrapartum Glucose Control

A NA study, sponsored by Medical College of Wisconsin.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT07571343: Clinical Trial NA study, sponsored by Medical College of Wisconsin.

NCT07571343 is a NA study that has not yet begun recruiting, run by Medical College of Wisconsin. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07571343, a NA study, has not yet begun recruiting, sponsored by Medical College of Wisconsin.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The goal of this study is to learn if high-protein drinks during labor can improve blood sugar control in pregnant women with insulin-treated diabetes. It will also help us learn if this approach is acceptable and well-tolerated by patients. The main questions it aims to answer are: * Does drinking high-protein beverages during labor keep blood sugar in a healthier range compared to drinking standard clear liquids? * How do participants feel about drinking protein beverages during labor, and does it affect their energy levels and birth experience? * Is the baby less likely to have low blood sugar after birth when the mother drinks protein beverages during labor? Researchers will compare women who drink high-protein beverages to women who drink standard clear liquids (like juice, broth, and popsicles) to see if protein drinks help keep blood sugar more stable during labor. Participants will: * Wear a small, painless glucose sensor on their arm from when labor starts until about one week after giving birth * Be randomly assigned to either drink a clear protein beverage every 4 hours during labor OR drink standard clear liquids as usual * Complete short surveys about how tired they feel during labor, their overall birth experience, and their overall experience with the glucose sensor

Primary Outcome

Percentage of CGM readings exceeding 110 mg/dL during labor, calculated as the proportion of valid CGM readings \>110 mg/dL divided by total valid readings, expressed as a percentage.

Interventions

  • DIETARY_SUPPLEMENT High-Protein Beverage (Genius Gourmet Sparkling Protein Water)
  • OTHER Standard Clear Liquid Diet
  • DEVICE Continuous Glucose Monitoring (Abbott Freestyle Libre)

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-07-01
Est. Completion 2028-07-30
Phase NA
Medical College of Wisconsin

447 total trials

What is known before NCT07571343 opens enrollment

NCT07571343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which High-Protein Beverage (Genius Gourmet Sparkling Protein Water) is the first listed.

NCT07571343 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07571343 about?

NCT07571343 is a clinical study titled "Fueling Labor: Protein Supplementation for Intrapartum Glucose Control". The goal of this study is to learn if high-protein drinks during labor can improve blood sugar control in pregnant women with insulin-treated diabetes. It will also help us learn if this approach is acceptable and well-tolerated by patients. The main questions it aims to answer are: * Does drinking...

What is the current status of trial NCT07571343?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-07-01. Estimated completion is 2028-07-30.

What interventions are being tested in trial NCT07571343?

The interventions under investigation include: High-Protein Beverage (Genius Gourmet Sparkling Protein Water) (DIETARY_SUPPLEMENT), Standard Clear Liquid Diet (OTHER), Continuous Glucose Monitoring (Abbott Freestyle Libre) (DEVICE).

Who is sponsoring clinical trial NCT07571343?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07571343's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07571343, the US trial registry maintained by the National Library of Medicine. NCT07571343 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.